Xyralid Hemorrhoidal
NDC 57483-410, Hemorrhoidal Suppositories, suppository, from Innovus Pharmaceuticals, Inc..
- Product NDC
- 57483-410
- Status
- Listed
- Labeler
- Innovus Pharmaceuticals, Inc.
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH FINAL
- Application
- part346
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57483-410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- COCOA BUTTER88.5 g/100g
- PHENYLEPHRINE HYDROCHLORIDE.26 g/100g
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57483-410-13 | 57483041013 | 4 BLISTER PACK in 1 CARTON (57483-410-13) / 24 g in 1 BLISTER PACK (57483-410-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 57483-410 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57483-410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57483-410. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.